Literature DB >> 1657717

A matched set of cat vectors for rapid mutational analysis of eukaryotic promoters and enhancers.

R R Iyer1.   

Abstract

The eukaryotic cat expression vectors, pBRAMScat1 and pBRAMScat2, were constructed to simplify the analysis of genomic fragments containing putative transcriptional regulatory elements. These vectors contain the f1 filamentous phage origin of replication for single-stranded DNA rescue, and permit site-directed mutagenesis, and dideoxy sequencing of nested deletion mutants using commercial T3, T7 and M13 universal forward/reverse primers. The above features eliminate the need to shuttle back and forth between a conventional cloning vector and the cat expression vector during the analysis of putative eukaryotic gene regulatory elements. Plasmid pBRAMScat1 contains the bacterial chloramphenicol acetyltransferase-encoding gene (cat) and no eukaryotic promoter and was designed for the analysis of eukaryotic promoters. Plasmid pBRAMScat2 contains the cat gene under the control of the Herpes simplex virus thymidine kinase promoter and was designed for the analysis of eukaryotic enhancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657717     DOI: 10.1016/0378-1119(91)90518-g

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism.

Authors:  C Perez; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

2.  The short transcript of Leishmania RNA virus is generated by RNA cleavage.

Authors:  K J MacBeth; J L Patterson
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

3.  Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus.

Authors:  Q G Eichbaum; R Iyer; D P Raveh; C Mathieu; R A Ezekowitz
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.